Jamaica's EVE for Life Model Shows Why Community Leadership Drives HIV/AIDS Care

Dr. Patricia Watson was washing her hands for thirty minutes when she should have been sleeping. It was 1999, and she had just left Jamaica AIDS Support's hospice after interviewing a man with HIV—a man so visibly ill that her instinct had been to recoil. Back at the Gleaner newsroom, where she worked as a health reporter, she scrubbed her skin raw, convinced she could catch the virus from a handshake. That night, unable to rest, she understood why: the man's face had become her father's face. She remembered him in Mandeville Hospital, gangrenous and scorned, while her siblings were the only ones who would touch him. The cringe and the scorn were the same thing. She made a promise to herself then that no one would be treated the way her father had been treated.

Twenty-five years later, that promise has shaped everything Watson has done. In 2008, she co-founded EVE for Life with Joy Crawford, an organization built on a simple but radical premise: that HIV care in Jamaica was failing adolescent girls and young women because no one had bothered to ask them what they actually needed. Watson and her team conducted focus groups and listened. What they heard was that girls did not understand why they had to take medication, or what HIV meant beyond a death sentence. They knew almost nothing about sexual health, contraception, or how to prevent transmission. They were isolated, depressed, and they needed to see women like themselves—women living with HIV—who could show them how to survive it.

The organization's Mentor Moms Initiative became the answer. It is built on a truth that institutions often miss: trust is not given to a system, it is given to a person. A fifteen-year-old will not tell a nurse that her mother's partner is the reason she is pregnant. But she will tell a woman who sits beside her and says, when I was fourteen, this is what happened to me. The mentors kept girls in treatment when clinics could not. They discovered abuse that intake forms never caught. They answered calls at nine at night from girls who were suicidal or ready to stop their medication. And something else happened: women who had spent years defined by HIV or violence stood in front of groups and became the person with the answers. Some of those mentors now work in Jamaica's Ministry of Health and in the health system in New York, doing the same work.

But Watson has learned something harder over four decades of the pandemic: treatment did not end the crisis. It only changed who the crisis falls on. Once medication works, HIV becomes a story about who can reach a clinic without being seen, who can swallow a pill without disclosure, who can tell someone without being put out of the house. These are not medical problems. They are housing problems, violence problems, stigma problems. A girl will always choose the man who might harm her tonight over a virus that might harm her in ten years. When she stops taking her medication, the system records it as non-adherence. What it actually is: she cannot take the pill in that house without someone finding out, and if someone finds out, she will be homeless.

Watson has watched girls default on treatment and be written up as failures. She has seen a girl's HIV suppressed completely while she was still being raped every week, and the system called that a success. She has seen national statistics look perfectly reasonable while a fifteen-year-old in St. Elizabeth has no confidential way to get tested. Averages hide people. They always have. And when budgets contract, the first things to go are the peer navigators, the transport stipends, the counseling—the soft costs, as funders call them. You can procure the medication perfectly and still lose her because nobody walked with her.

What gives Watson hope is that the girls are not waiting anymore. A young woman in a rural parish who would once have been a name on a list is now running a peer network and sitting in national consultations, saying out loud what the rest of them tiptoe around. The tools have shifted too: long-acting injectables and implants mean a girl can now protect herself without anyone's permission and without anyone knowing. For a woman in a violent relationship, that is the difference between being able to protect herself and not. But the future Watson wants is simpler than that. She wants a girl's safety to not depend on whether she lives below Cross Roads or in deep rural St. Andrew. She wants sustained, unrestricted, multi-year funding for organizations led by people living with HIV. She wants mental health support built into HIV care, not referred out to a system that does not exist. She wants long-acting prevention priced so that Jamaica's health system can actually buy it. And she wants adolescent services that do not require a parent's signature, because for some girls the person they need protection from is the person whose signature is required. The work is not about the virus alone. It never has been.